Jarosław Paluszczak

20PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsChemotherapyNatural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 26, 2026
The Inhibition of Histone Lysine Demethylases Affects Head and Neck Cancer Cell Growth and Response to Cisplatin.

|Mar 01, 2026
The methylation of LHX2, RAPGEFL1, RARB and RYR2 has prognostic significance in head and neck squamous cell carcinoma patients.

Marcin Skalski, Ewelina Kowal-Wiśniewska, Katarzyna Jaskiewicz-Rajewicz

|Sep 13, 2025
The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence.

Jarosław Paluszczak, Robert Kleszcz

|Aug 28, 2025
Formulation of Honokiol- and Magnolol-Loaded Nanoemulsions for Head and Neck Cancer Adjuvant Therapy: Evaluation of Radiation Sterilization Effects on Active Substance Properties.

Katarzyna Dominiak, Aleksandra Gostyńska-Stawna, Agnieszka Sobczak

|Oct 25, 2024
Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth.

Robert Kleszcz, Dawid Dorna, Maciej Stawny

|Jun 27, 2024
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.

Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak

Pageof 4

Frequent Collaborators

11 joint publications

Robert Kleszcz

7 joint publications

Dawid Dorna

4 joint publications

Violetta Krajka-Kuźniak

2 joint publications

Elżbieta Studzińska-Sroka